Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy

American Journal of Kidney Diseases

Volumn 28, Issue 4, 1996, Pages 618-621

  Briggs, William A ^a,b   Tanawattanacharoen, Somsak ^a   Choi, Michael J ^a   Scheel Jr , Paul J ^a   Nadasdy, Tibor ^a   Racusen, Lorraine ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV associated nephropathy; Prednisone; renal failure

Indexed keywords

PREDNISONE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CASE REPORT; GLOMERULOSCLEROSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY BIOPSY; KIDNEY DISEASE; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MALE; MICROANGIOPATHY; MONONUCLEAR CELL; SEROCONVERSION; URINARY EXCRETION;

EID: 0029792938     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90477-1     Document Type: Article

References (21)

1. Kimmel PL, Phillips TO, Furreira-Centeno A, Farkas-Szallasi T, Abraham AA, Garrett CT: HIV-associated immune-mediated renal disease. Kidney Int 44:1327-1340, 1993
2. Casanova S, Mazzucco G, di Belgiojoso B, Motta M, Boldorini R, Genderini A, Monga G: Pattern of glomerular involvement in human immunodeficiency virus-infected patients: An Italian study. Am J Kidney Dis 26:446-453, 1995
3. D'Agati V, Il Suh J, Carbone L, Cheng JT, Appel G: Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35:1358-1370, 1989
4. Bourgoignie JJ: Renal complication of human immunodeficiency virus type I. Kidney Int 37:1571-1584, 1990
5. Humphreys MH: Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 48:311-320, 1995
6. Sreepada Rao TK: Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int 40:S13-S18, 1991 (suppl 35)
7. Smith MC, Pawar R, Carey JT, Graham RC Jr, Jacobs GH, Menon A, Salata RA, Seliga R, Kalayjian RC: Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy. Am J Med 97:145-151, 1994
8. Phinney M, Austen J, Pawar R, Rahman M, Carey J, Kalayjian R, Weigel K, Smith MC: Prednisone improves renal function and proteinuria in HIV-associated nephropathy. J Am Soc Nephrol 5:358, 1994
9. Babut-Gay ML, Echard M, Kleinknecht D, Meyrier A: Zidovudine and nephropathy with human immunodeficiency virus (HIV) infection. Ann Intern Med 111:856-857, 1989
10. Lam M, Park MC: HIV-associated nephropathy: Beneficial effect of zidovudine therapy. N Engl J Med 323:1775-1776, 1990
11. Ifudu O, Rao TKS, Tan CC, Fleischman H, Chirgwin K, Friedman EA: Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol 15:217-221, 1995
12. Nielsen TL, Eeftnick Schattenkerk JKM, Jensen BN, Lundgren JD, Gerstot J, vanSteenwijk, Bentsen K, Frissen PHJ, Gaub J, Orholm M, Hansen J-E, Mathiesen L, Skinhoj P, Nielsen JO: Adjunctive corticosteroid therapy for pneumocystis carinii pneumonia in AIDS: A randomized European multicenter open label study. J Acquir Immune Defic Syndr 5:726-731, 1992
13. Rigaud M, Leibovitz E, Quee CS, Kaul A, Nardi M, Pollack H, Lawrence R, DiJohn D, Krasinski K, Karpatkin M, Gorkowsky W: Thrombocytopenia in children infected with human immunodeficiency virus: Long-term follow-up and therapeutic considerations. J Acquir Immune Defic Syndr 5:450-455, 1992
14. Wilcox CM, Schwartz DA: A pilot study of oral corticosteroid therapy for idiopathic esophageal ulcerations associated with human immunodeficiency virus infection. Am J Med 93:131-134, 1992
15. Rappaport J, Kopp JB, Klotman PE: Host virus interactions and the molecular regulation of HIV-1: Role in the pathogenesis of HIV-associated nephropathy. Kidney Int 46:16-27, 1994
16. Zinkernagel RM, Hengartner H: T-cell-mediated immunopathology versus direct cytolysis by virus: Implications for HIV and AIDS. Immunol Today 15:262-268, 1994
17. Atlan H, Gersten MJ, Salk PL, Salk J: Mechanisms of autoimmunity and AIDS: Prospects for therapeutic intervention. Res Immunol 145:165-183, 1994
18. Andrieu J-M, Lu W, Levy R: Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. J Infect Dis 171:523-530, 1995
19. Corey L: Editorial: Reducing T cell activation as a therapy for human immunodeficiency virus infection. J Infect Dis 171:521-522, 1995
20. Thompson CE, Damon LE, Linker CA: Thrombotic microangiopathies in the 1980's: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 80:1890-1895, 1992
21. Ucar A, Fernandez HF, Byrnes JJ, Lian Ec-Y, Harrington WJ: Thrombotic microangiopathy and retroviral infections: A 13 year experience. Am J Hematol 45:304-309, 1994